Comparative cytokine gene expression in synovial tissue of early rheumatoid arthritis and seronegative spondyloarthropathies

British Journal of Rheumatology

Volumn 36, Issue 1, 1997, Pages 38-42

  Canete J D ^a,b   Llena, J ^a   Collado, A ^a   Sanmarti R ^a   Gaya A ^a   Gratacos J ^a   Blay, M ^a   Munoz Gomez J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Cytokine; Early disease; Gene; PCR; Rheumatoid arthritis; Seronegative spondyloarthropathies; Synovium

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; RHEUMATOID FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FIBROBLAST; GENDER; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KNEE; MACROPHAGE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY; SYNOVITIS; SYNOVIUM; T LYMPHOCYTE;

EID: 0343907263     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/36.1.38     Document Type: Article

References (28)

1. Feldmann M, Brennan F, Maini RN. Role of cytokines in autoimmune disease. In: Oppeheim JJ, Rossio JL, Gearing AJH, eds. Clinical applications of cytokines. Role in pathogenesis, diagnosis and therapy. Oxford: Oxford University Press, 1993:109-13.
2. Arend WP, Dayer JM. Cytokines and growth factors. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB, eds. Textbook of rheumatology, 4th edn. Philadelphia: WB Saunders, 1993:227-47.
3. Nabil M, Yanni G, Poston R, Panayi GS. Cytokine expression in synovial membranes of patients with rheumatoid arthritis. Ann Rheum Dis 1994;52:870-5.
4. Ulfgren AK, Lindblad S, Klareskog L, Anderson J, Anderson U. Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis 1995;54:654-61.
5. Buchan G, Barret K, Turner M, Chantry D, Maini RN, Feldmann M. Interleukin-1 and tumor necrosis factor-α mRNA expression in rheumatoid arthritis: prolonged production of IL-1α. Clin Exp Immunol 1988;3:449-55.
6. Firestein GS, Alvaro-Gracia JM, Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 1990;144:3347-53.
7. Wood NC, Simons JA, Dickens E, Duff GW. In situ hybridization of IL-6 in rheumatoid arthritis. Clin Exp Immunol 1992;87:183-9.
8. Miossec P. Cytokine abnormalities in inflammatory arthritis. Baillière's Clin Rheumatol 1992;6:373-92.
9. Chen E, Keystone EC, Fish EN. Restricted cytokine expression in rheumatoid arthritis. Arthritis Rheum 1993;36:901-10.
10. Barrera P, Boerbooms AMTH, Jannssen EM et al. Circulating soluble TNF receptors, interleukin-2 receptor, tumor necrosis factor-α and interleukin-6 levels in rheumatoid arthritis: longitudinal evaluation during methotrexate and azathioprine therapy. Arthritis Rheum 1993;36:1070-9.
11. Crilly A, Madhok R, Watson J, Capell HA, Sturrock RD. Production of interleukin-6 by monocytes isolated from rheumatoid arthritis patients receiving second-line drug therapy. Br J Rheumatol 1994;33:821-5.
12. Dolhain RJ, de Kuiper P, Verweij CL et al. Tenidap, but not nonsteroidal anti-inflammatory drugs, inhibits T-cell proliferation and cytokine induction. Scand J Immunol 1995;42:686-93.
13. Thompson PW, Silman AJ, Kirwan SR, Currey HLF. Articular index of joint inflammation in rheumatoid arthritis. Correlation with the acute-phase response. Arthritis Rheum 1987;6:618-23.
14. Esteve-Vives J, Batlle E, el Grupo para la Adaptación del HAQ a la Población Española. Adaptación del Health Assessment Questionnaire (HAQ) a la población española. Rev Esp Reumatol 1991;18:258-62.
15. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 1987;162:156-9.
16. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Plainview, NY: Cold Spring Harbor Laboratory Press, 1989.
17. Chu CQ, Field M, Feldmann M, Maini RN. Localization of tumor necrosis factor-α in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1125-32.
18. Miossec P, Naviliat M, Dupuy A, Sany J, Banchereau J. Low levels of interleukin-4 and high levels of transforming growth factor-β in rheumatoid synovitis. Arthritis Rheum 1990;33:1180-7.
19. Jendro M, Ganten T, Matteson EL, Weyand CM, Goronzy JJ. Emergence of oligoclonal T cell populations following therapeutic T cell depletion in rheumatoid arthritis. Arthritis Rheum 1995;9:1242-51.
20. Panayi GS, Lanchbury JS, Kingsley GH. The importance of T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 1992;36:729-35.
21. Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994;91:8562-6.
22. Ahuja SS, Paliogianni F, Yamada K, Balow JB, Bonumpas DT. Effect of transforming growth factor-β on early and late activation events in human T cell. J Immunol 1993;150:109-18.
23. Zvaifler NJ, Boyle D, Firestein GS. Early synovitis - synoviocytes and mononuclear cells. Semin Arthritis Rheum 1994;23:11-6.
24. Firestein GS, Zvaifler NJ. How important are T cells in chronic rheumatic synovitis? Arthritis Rheum 1990;33:768-73.
25. Firestein GS, Zvaifler NJ. The role of T cells in rheumatoid arthritis. Ann Rheum Dis 1993;52:765.
26. Maini RN, Elliot MJ, Brennan FM et al. Monoclonal anti-TNFα antibody as a probe of pathogenesis and therapy of rheumatoid disease. Immunol Rev 1995;144:195-223.
27. Aho K, Paulusuo T, Kurki P. Marker antibodies of rheumatoid arthritis: Diagnostic and pathogenetic implications. Semin Arthritis Rheum 1994;23:379-87.
28. Gratacós J, Collado A, Filella X et al. Serum cytokines (IL-6, TNFα, IL1β and γIFN) in ankylosing spondylitis: A close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 1994;33:927-31.